Lysosome biogenesis in health and disease

Lakshya Bajaj; Parisa Lotfi; Rituraj Pal; Alberto di Ronza; Jaiprakash Sharma; Marco Sardiello

doi:10.1111/jnc.14564

journal article Oct 18, 2018

Lysosome biogenesis in health and disease

Lakshya Bajaj Parisa Lotfi Rituraj Pal Alberto di Ronza Jaiprakash Sharma Marco Sardiello

Journal of Neurochemistry Vol. 148 No. 5 pp. 573-589 · Wiley

View at Publisher Save 10.1111/jnc.14564

Abstract

AbstractThis review focuses on the pathways that regulate lysosome biogenesis and that are implicated in numerous degenerative storage diseases, including lysosomal storage disorders and late‐onset neurodegenerative diseases. Lysosomal proteins are synthesized in the endoplasmic reticulum and trafficked to the endolysosomal system through the secretory route. Several receptors have been characterized that execute post‐Golgi trafficking of lysosomal proteins. Some of them recognize their cargo proteins based on specific amino acid signatures, others based on a particular glycan modification that is exclusively found on lysosomal proteins. Nearly all receptors serving lysosome biogenesis are under the transcriptional control of transcription factor EB (TFEB), a master regulator of the lysosomal system. TFEB coordinates the expression of lysosomal hydrolases, lysosomal membrane proteins, and autophagy proteins in response to pathways sensing lysosomal stress and the nutritional conditions of the cell among other stimuli. TFEB is primed for activation in lysosomal storage disorders but surprisingly its function is impaired in some late‐onset neurodegenerative storage diseases like Alzheimer's and Parkinson's, because of specific detrimental interactions that limit TFEB expression or activation. Thus, disrupted TFEB function presumably plays a role in the pathogenesis of these diseases. Multiple studies in animal models of degenerative storage diseases have shown that exogenous expression of TFEB and pharmacological activation of endogenous TFEB attenuate disease phenotypes. These results highlight TFEB‐mediated enhancement of lysosomal biogenesis and function as a candidate strategy to counteract the progression of these diseases.
image
This article is part of the Special Issue “Lysosomal Storage Disorders”.

Topics

No keywords indexed for this article. Browse by subject →

References

172

[1]

10.1074/jbc.m006279200

[2]

10.1073/pnas.0503689102

[3]

10.1016/j.survophthal.2005.11.007

[4]

10.1016/0092-8674(90)90161-7

[5]

10.1093/hmg/ddi458

[6]

10.1016/j.ajhg.2007.12.019

[7]

10.1093/hmg/ddp523

[8]

10.1111/tra.12313

[9]

10.1146/annurev.biochem.72.121801.161800

[10]

10.1080/15548627.2015.1134081

[11]

10.1038/nrneurol.2013.163

[12]

10.1016/j.bbamcr.2008.10.016

[13]

Busch J. I. "Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72‐dependent alterations in lysosomes" Hum. Mol. Genet. (2016)

[14]

10.1074/jbc.m110.100420

[15]

10.1016/j.bbrc.2008.06.021

[16]

10.1016/j.bbadis.2015.04.027

[17]

10.1007/s00109-014-1152-3

[18]

10.1038/ng.3955

[19]

10.1038/s41598-018-19744-w

[20]

10.1021/bi7011806

[21]

10.1038/cr.2017.45

[22]

10.1084/jem.129.1.201

[23]

10.1038/nn.3787

[24]

10.1016/s0092-8674(03)00348-9

[25]

10.2217/clp.11.70

[26]

10.1126/science.1101738

[27]

10.1016/s0021-9258(17)36649-8

[28]

Dahms N. M. "The cation‐dependent mannose 6‐phosphate receptor. Structural requirements for mannose 6‐phosphate binding and oligomerization" J. Biol. Chem. (1989) 10.1016/s0021-9258(18)60486-7

[29]

10.1016/s0896-6273(03)00568-3

[30]

10.1042/bj0600604

[31]

10.1073/pnas.1305623110

[32]

10.1523/jneurosci.1920-10.2010

[33]

10.1001/archneurol.2011.120

[34]

10.1016/s0092-8674(03)00347-7

[35]

10.1146/annurev.genom.6.080604.162334

[36]

10.1074/jbc.m202369200

[37]

10.1371/journal.pgen.1002141

[38]

10.1038/s12276-017-0007-8

[39]

10.1073/pnas.97.16.9287

[40]

10.1083/jcb.201003021

[41]

Foo J. N. "Rare lysosomal enzyme gene SMPD1 variant (p. R591C) associates with Parkinson's disease" Neurobiol. Aging (2013)

[42]

10.1093/hmg/ddg062

[43]

10.1212/wnl.0b013e31828f180e

[44]

10.1136/jmg.2004.024455

[45]

10.1126/science.1098966

[46]

10.15252/emmm.201404190

[47]

10.1016/s0021-9258(18)53945-4

[48]

10.1002/mrd.20096

[49]

10.1006/bbrc.1999.1822

[50]

10.1074/jbc.m210851200

Showing 50 of 172 references

Cited By

133

Arylsulfatase I is a novel lysosomal chondroitin endosulfatase regulating endochondral ossification

Rafaela Grecco-Machado, Satomi Nadanaka · 2026

Matrix Biology

The autophagy protein ATG-9 regulates lysosome function and integrity

Kangfu Peng, Guoxiu Zhao · 2025

The Journal of cell biology

Mitochondrial dysfunction in Alzheimer’s disease

Maria Clara Bila D’Alessandro, Salim Kanaan · 2025

Ageing Research Reviews

Lysosome biogenesis: Regulation and functions

Chonglin Yang, Xiaochen Wang · 2021

The Journal of cell biology

Adapting the proteostasis capacity to sustain brain healthspan

Claudio Hetz · 2021

Cell

Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches

Noelia Benetó, Lluïsa Vilageliu · 2020

International Journal of Molecular...

Metrics

133

Citations

172

References

Details

Published: Oct 18, 2018
Vol/Issue: 148(5)
Pages: 573-589
License: View

Authors

L

Lakshya Bajaj